SCHEMBL6712151

SCHEMBL6712151

COc1ccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.48
PDGFRB P09619 2/20 0.48
KDM4E B2RXH2 4/20 0.48
MAPT P10636 3/20 0.48
ALDH1A1 P00352 3/20 0.48
POLB P06746 2/20 0.47
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALOX15 P16050 4/20 0.44
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MAP3K5 Q99683 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711722 0.93 KDM4E (0.57) FLT3PDGFRBKDM4EMAPTALDH1A1
SCHEMBL6708921 0.90 ALOX15 (0.51) MEN1KMT2AALOX15RXFP1
SCHEMBL6711679 0.89 GPR35 (0.50) FLT3PDGFRBKDM4EMAPTALDH1A1
SCHEMBL6710058 0.86 KDM4E (0.42) FLT3PDGFRBKDM4EMAPTALDH1A1
SCHEMBL6708753 0.85 FLT3 (0.45) FLT3PDGFRBKDM4EALDH1A1MEN1
SCHEMBL6711642 0.84 NHERF1 (0.49) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL6709221 0.84 ALOX15 (0.46) ALOX15
SCHEMBL6711395 0.83 FLT3 (0.48) FLT3PDGFRBKDM4EMAPTALDH1A1
SCHEMBL6708816 0.81 ALOX15 (0.44) MEN1KMT2AALOX15RXFP1
SCHEMBL6707911 0.81 KDM4E (0.57) FLT3PDGFRBKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 FLT3 1614/4885PDGFRB 236/4885KDM4E 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.